Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis

Journal of Clinical Microbiology

Volumn 45, Issue 10, 2007, Pages 3257-3262

  Hallander, Hans ^a   Advani, Abdolreza ^a   Riffelmann, Marion ^b   Von König, Carl H W ^b   Caro, Valerie ^c   Guiso, Nicole ^c   Mooi, Frits R ^d   Gzyl, Anna ^e   Kaltoft, Margit S ^f   Fry, Norman K ^g   Mertsola, Jussi ^h   He, Qiushui ⁱ  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^b Institut fuer Infektiologie Krefeld   (Germany)

^c INSTITUT PASTEUR   (France)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e NATIONAL INSTITUTE OF HYGIENE   (Poland)

^f STATENS SERUM INSTITUT   (Denmark)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h UNIVERSITY OF TURKU   (Finland)

ⁱ NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BORDETELLA PERTUSSIS; DENMARK; EUROPE; FINLAND; FRANCE; GERMANY; NETHERLANDS; NONHUMAN; PHYLOGENETIC TREE; POLAND; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SWEDEN; UNITED KINGDOM;

BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; ELECTROPHORESIS, GEL, PULSED-FIELD; EUROPE; HUMANS; INFANT; INFANT, NEWBORN; PERTUSSIS VACCINE; TIME FACTORS; VACCINATION;

BORDETELLA PERTUSSIS;

EID: 35348866259     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00864-07     Document Type: Article

References (27)

1. Advani, A., D. Donnelly, L. Gustafsson, and H. O. Hallander. 2007. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004. APMIS 115:299-310.
2. Advani, A., D. Donnelly, and H. Hallander. 2004. Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J. Clin. Microbiol. 42:2890-2897.
3. Advani, A., L. Gustafsson, R.-M. Carlsson, D. Donnelly, and H. Hallander. 2007. Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype. APMIS 115:736-742.
4. Bisgard, K. M., C. D. Christie, S. F. Reising, G. N. Sanden, P. K. Cassiday, C. Gomersall, W. A. Wattigney, N. E. Roberts, and P. M. Strebel. 2001. Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996. J. Infect. Dis. 183:1360-1367.
5. Caro, V., A. Elomaa, D. Brun, J. Mertsola, Q. He, and N. Guiso. 2006. Bordetella pertussis, Finland and France. Emerg. Infect. Dis. 12:987-989.
6. Caro, V., D. Hot, G. Guigon, C. Hubans, M. Arrive, G. Soubigou, G. Renauld-Mongenie, R. Antoine, C. Locht, Y. Lemoine, and N. Guiso. 2006. Temporal analysis of French Bordetella pertussis isolates by comparative whole-genome hybridization. Microbes Infect. 8:2228-2235.
7. Caro, V., E. Njamkepo, S. C. Van Amersfoorth, F. R. Mooi, A. Advani, H. O. Hallander, Q. He, J. Mertsola, M. Riffelmann, C. Vahrenholz, C. H. Von Konig, and N. Guiso. 2005. Pulsed-field gel electrophoresis analysis of Bordetella pertussis populations in various European countries with different vaccine policies. Microbes Infect. 7:976-982.
8. Celentano, L. P., M. Massari, D. Paramatti, S. Salmaso, and A. E. Tozzi. 2005. Resurgence of pertussis in Europe. Pediatr. Infect. Dis. J. 24:761-765.
9. Cummings, C. A., M. M. Brinig, P. W. Lepp, S. van de Pas, and D. A. Relman. 2004. Bordetella species are distinguished by patterns of substantial gene loss and host adaptation. J. Bacteriol. 186:1484-1492.
10. Elomaa, A., A. Advani, D. Donnelly, M. Antila, J. Mertsola, Q. He, and H. Hallander. 2007. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories. Vaccine 25:918-926.
11. Hallander, H. O., A. Advani, D. Donnelly, L. Gustafsson, and R.-M. Carlsson. 2005. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J. Clin. Microbiol. 43:2856-2865.
12. Kodama, A., K. Kamachi, Y. Horiuchi, T. Konda, and Y. Arakawa. 2004. Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan. J. Clin. Microbiol. 42:5453-5457.
13. Lee, Y. S., C. Y. Yang, C. H. Lu, and Y. H. Tseng. 2003. Molecular epidemiology of Bordetella pertussis isolated in Taiwan, 1992-1997. Microbiol. Immunol. 47:903-909.
14. Lin, Y.-C., S.-M. Yao, J.-J. Yan, Y.-Y. Chen, M.-J. Hsiao, C.-Y. Chou, H.-P. Su, H.-S. Wu, and S.-Y. Li. 2006. Molecular epidemiology of Bordetella pertussis in Taiwan, 1993-2004: suggests one possible explanation for the outbreak of pertussis in 1997. Microbes Infect. 8:2082-2087.
15. McIntyre, P., H. Gidding, R. Gilmour, G. Lawrence, B. Hull, P. Horby, H. Wang, R. Andrews, M. Burgess, and National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. 2002. Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000. Commonwealth Dept. of Health and Ageing, Canberra, Australia.
16. Mooi, F. R., H. Hallander, C. H. Wirsing von Konig, B. Hoet, and N. Guiso. 2000. Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur. J. Clin. Microbiol. Infect. Dis. 19:174-181.
17. Mooi, F. R., I. H. van Loo, and A. J. King. 2001. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence? Emerg. Infect. Dis. 7:526-528.
18. Mooi, F. R., H. van Oirschot, K. Heuvelman, H. G. van der Heide, W. Gaastra, and R. J. Willems. 1998. Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect. Immun. 66:670-675.
19. Ntezayabo, B., G. De Serres, and B. Duval. 2003. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr. Infect. Dis. J. 22:22-27.
20. Schouls, L. M., H. G. J. van der Heide, L. Vauterin, P. Vauterin, and F. R. Mooi. 2004. Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J. Bacteriol. 186:5496-5505.
21. Tsang, R. S. W., A. K. H. Lau, M. L. Sill, S. A. Halperin, P. Van Caeseele, F. Jamieson, and I. E. Martin. 2004. Polymorphisms of the fimbria fim3 gene of Bordetella pertussis strains isolated in Canada. J. Clin. Microbiol. 42:5364-5367.
22. van Amersfoorth, S. C. M., L. M. Schouls, H. G. J. van der Heide, A. Advani, H. O. Hallander, K. Bondeson, C. H. W. von Konig, M. Riffelmann, C. Vahrenholz, N. Guiso, V. Caro, E. Njamkepo, Q. He, J. Mertsola, and F. R. Mooi. 2005. Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J. Clin. Microbiol. 43:2837-2843.
23. van der Zee, A., S. Vernoolj, M. Peeters, J. van Embden, and F. R. Mooi. 1996. Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution. Microbiology 142:3479-3485.
24. van Loo, I. H., K. J. Heuvelman, A. J. King, and F. R. Mooi. 2002. Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J. Clin. Microbiol. 40:1994-2001.
25. Weber, C., C. Boursaux-Eude, G. Coralie, V. Caro, and N. Guiso. 2001. Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years. J. Clin. Microbiol. 39:4396-4403.
26. World Health Organization. 2001. Pertussis surveillance: a global meeting, Geneva, 16-18 October 2000. World Health Organization document no. WHO/V&B/01.19. Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. http://www.who.int/vaccines-documents/ DocsPDF01/www605.pdf.
27. Zanardi, L., F. Pascual, K. Bisgard, T. Murphy, and M. Wharton. 2002. Pertussis - United States, 1997-2000. Morb. Mortal. Wkly. Rep. 51:73-76.